The U.S. Food and Drug Administration (FDA) has announced that it is extending the comment period on its draft guidance regarding voluntary disclosure of sesame as an allergen to February 25, 2021, an extension of 45 days. Comments should be submitted before February 25, 2021 to ensure that FDA considers them before beginning work on the final guidance.

Comments on the draft voluntary sesame labeling guidance should be submitted to Submit written comments to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville MD 20852. All written comments should be identified with this document's docket number: FDA-2020-D-0530.

Lisa Gable, CEO of Food Allergy Research & Education, stated that her organization is “grateful for the extension as it affords an opportunity for the 1.5 million who are allergic to sesame and the more than 32 million Americans suffering from potentially life-threatening food allergies to share their thoughts and feelings on this incredibly important issue.”

Read the original announcement here.